The solid state

A.J. Florence, Alexander Florence (Editor), Juergen Siepmann (Editor)

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Many active pharmaceutical ingredients (APIs) can exist in more than one solid-state form, including crystalline polymorphs, solvates, salts, cocrystals, and noncrystalline or amorphous solids (Fig. 1; Table 1). Hence, assessment and control of the solid-state structure of APIs is necessary to ensure efficient and reproducible processing, manufacturing, and storage; to satisfy regulatory authorities; to protect intellectual property; and ultimately to deliver safe, effective, and high-quality medicinal products. This section introduces key practical aspects of solid-state pharmaceuticals, with a specific emphasis on crystalline solids and their preparation, handling, and analysis, particularly in the context of preclinical drug development and pharmaceutical manufacture.
LanguageEnglish
Title of host publicationModern pharmaceutics, Fifth Edition
Place of PublicationNew York, USA
Number of pages500
Volume1
Publication statusPublished - May 2009

Fingerprint

Pharmaceutical Preparations
Intellectual property
Crystallization
Salts
Crystalline materials
Processing

Keywords

  • solid state
  • drug delivery
  • excipients
  • tablets
  • aerosols
  • techniques
  • pharmaceuticals
  • drug absorption
  • pharmacokinetics
  • dose forms
  • preformulation
  • optimization
  • systems
  • release
  • bioequivalence
  • processes
  • products
  • pharmaceutics
  • personalized medicines
  • evaluation
  • physics
  • in vivo imaging
  • biotechnology

Cite this

Florence, A. J., Florence, A. (Ed.), & Siepmann, J. (Ed.) (2009). The solid state. In Modern pharmaceutics, Fifth Edition (Vol. 1). New York, USA.
Florence, A.J. ; Florence, Alexander (Editor) ; Siepmann, Juergen (Editor). / The solid state. Modern pharmaceutics, Fifth Edition. Vol. 1 New York, USA, 2009.
@inbook{6f22f93e18c747cbb81727c1221852a3,
title = "The solid state",
abstract = "Many active pharmaceutical ingredients (APIs) can exist in more than one solid-state form, including crystalline polymorphs, solvates, salts, cocrystals, and noncrystalline or amorphous solids (Fig. 1; Table 1). Hence, assessment and control of the solid-state structure of APIs is necessary to ensure efficient and reproducible processing, manufacturing, and storage; to satisfy regulatory authorities; to protect intellectual property; and ultimately to deliver safe, effective, and high-quality medicinal products. This section introduces key practical aspects of solid-state pharmaceuticals, with a specific emphasis on crystalline solids and their preparation, handling, and analysis, particularly in the context of preclinical drug development and pharmaceutical manufacture.",
keywords = "solid state, drug delivery, excipients, tablets, aerosols, techniques, pharmaceuticals, drug absorption, pharmacokinetics, dose forms, preformulation, optimization, systems, release, bioequivalence, processes, products, pharmaceutics, personalized medicines, evaluation, physics, in vivo imaging, biotechnology",
author = "A.J. Florence and Alexander Florence and Juergen Siepmann",
year = "2009",
month = "5",
language = "English",
isbn = "9781420065657",
volume = "1",
booktitle = "Modern pharmaceutics, Fifth Edition",

}

Florence, AJ, Florence, A (ed.) & Siepmann, J (ed.) 2009, The solid state. in Modern pharmaceutics, Fifth Edition. vol. 1, New York, USA.

The solid state. / Florence, A.J.; Florence, Alexander (Editor); Siepmann, Juergen (Editor).

Modern pharmaceutics, Fifth Edition. Vol. 1 New York, USA, 2009.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

TY - CHAP

T1 - The solid state

AU - Florence, A.J.

A2 - Florence, Alexander

A2 - Siepmann, Juergen

PY - 2009/5

Y1 - 2009/5

N2 - Many active pharmaceutical ingredients (APIs) can exist in more than one solid-state form, including crystalline polymorphs, solvates, salts, cocrystals, and noncrystalline or amorphous solids (Fig. 1; Table 1). Hence, assessment and control of the solid-state structure of APIs is necessary to ensure efficient and reproducible processing, manufacturing, and storage; to satisfy regulatory authorities; to protect intellectual property; and ultimately to deliver safe, effective, and high-quality medicinal products. This section introduces key practical aspects of solid-state pharmaceuticals, with a specific emphasis on crystalline solids and their preparation, handling, and analysis, particularly in the context of preclinical drug development and pharmaceutical manufacture.

AB - Many active pharmaceutical ingredients (APIs) can exist in more than one solid-state form, including crystalline polymorphs, solvates, salts, cocrystals, and noncrystalline or amorphous solids (Fig. 1; Table 1). Hence, assessment and control of the solid-state structure of APIs is necessary to ensure efficient and reproducible processing, manufacturing, and storage; to satisfy regulatory authorities; to protect intellectual property; and ultimately to deliver safe, effective, and high-quality medicinal products. This section introduces key practical aspects of solid-state pharmaceuticals, with a specific emphasis on crystalline solids and their preparation, handling, and analysis, particularly in the context of preclinical drug development and pharmaceutical manufacture.

KW - solid state

KW - drug delivery

KW - excipients

KW - tablets

KW - aerosols

KW - techniques

KW - pharmaceuticals

KW - drug absorption

KW - pharmacokinetics

KW - dose forms

KW - preformulation

KW - optimization

KW - systems

KW - release

KW - bioequivalence

KW - processes

KW - products

KW - pharmaceutics

KW - personalized medicines

KW - evaluation

KW - physics

KW - in vivo imaging

KW - biotechnology

UR - http://informahealthcare.com/doi/abs/10.3109/9781420065657.008?prevSearch=allfield%253A%2528Modern%2BPharmaceutics%2529%2Band%2B%2528allfield%253A%2528florence%2529%2529&searchHistoryKey=

M3 - Chapter

SN - 9781420065657

VL - 1

BT - Modern pharmaceutics, Fifth Edition

CY - New York, USA

ER -

Florence AJ, Florence A, (ed.), Siepmann J, (ed.). The solid state. In Modern pharmaceutics, Fifth Edition. Vol. 1. New York, USA. 2009

Access to Document